Norethindrone: Clinical Trials

10 trials of Norethindrone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 10 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 110Completed 10

Follow Norethindrone: new trials by email Literature Review of Norethindrone trials Research Report on Norethindrone

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Drug-drug Interaction of BMS-986196 With Oral Contraceptives in Healthy Female Participants
BMS-986196, Loestrin - Healthy Female Volunteers
Phase 1CompletedBristol-Myers Squibb152023-06-062023-09-25
Effect of Evobrutinib on Pharmacokinetics of a Combined Oral Contraceptive
Evobruitnib, Combined oral contraceptive [ethinyl estradiol/ norethisterone (EE/NET)] - Healthy
Phase 1CompletedMerck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany202022-08-242025-11-14
Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers
Microgestin®, Levothyroxine, Glyburide - Healthy Volunteers
Phase 1CompletedIronwood Pharmaceuticals, Inc.872019-03-112019-07-29
Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam
levonorgestrel/ Microlut, Norethindrone/ Noriday, Desogestrel/ Cerazette - Biological Availability
Phase 1CompletedBayer682017-11-292020-04-15
A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid Tumors
Trametinib, Oral Contraceptive (1mg norethindrone, 0.035mg ethinyl estradiol) - Solid Tumors
Phase 1CompletedNovartis Pharmaceuticals192016-10-202022-02-09
A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone
Ethinylestradiol, Norethindrone, JNJ-63623872 - Healthy
Phase 1CompletedJanssen Research & Development, LLC182015-12-012016-06-06
Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone
isavuconazole, Oral Contraceptive (ethinyl estradiol / norethindrone) - Pharmacokinetics of Isavuconazole, Pharmacokinetics of Ethinyl Estradiol and Norethindrone
Phase 1CompletedAstellas Pharma Global Development, Inc.242012-04-012012-07-16
Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female Subjects
ethinyl estradiol, norethindrone, VI-0521 - Healthy
Phase 1CompletedVIVUS LLC202009-01-012009-12-02
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions
Norethindrone/Ethinyl Estradiol, FEMCON® Fe - Healthy
Phase 1CompletedTeva Pharmaceuticals USA362008-08-012011-05-30
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions
Norethindrone/Ethinyl Estradiol, Ovcon® 35 Fe - Bioequivalence
Phase 1CompletedTeva Pharmaceuticals USA362006-12-012011-05-25

Sponsors

Teva Pharmaceuticals USA (2)  ·  Astellas Pharma Global Development, Inc. (1)  ·  Bayer (1)  ·  Bristol-Myers Squibb (1)  ·  Ironwood Pharmaceuticals, Inc. (1)  ·  Janssen Research & Development, LLC (1)  ·  Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1)  ·  Novartis Pharmaceuticals (1)  ·  VIVUS LLC (1)

Countries

United States (7)  ·  Belgium (2)  ·  Germany (2)  ·  Netherlands (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Scott Sharples, M.D. (1)  ·  Shiyin Yee (1)  ·  Zurab Machaidze, MD (1)

NIH funding

2015 (1), 2017 (1)